Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Nov;107 Suppl 1(0 1):63-73.
doi: 10.1111/j.1360-0443.2012.04040.x.

Neonatal neurobehavior effects following buprenorphine versus methadone exposure

Mara G Coyle  1 , Amy L Salisbury, Barry M Lester, Hendrée E Jones, Hai Lin, Klaudia Graf-Rohrmeister, Gabriele Fischer
Affiliations
Randomized Controlled Trial

Neonatal neurobehavior effects following buprenorphine versus methadone exposure

Mara G Coyle et al. Addiction. 2012 Nov.

Abstract

Aim: To determine the effects of in utero exposure to methadone or buprenorphine on infant neurobehavior.

Design: Three sites from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a double-blind, double-dummy, randomized clinical trial participated in this substudy.

Setting: Medical Centers that provided comprehensive maternal care to opioid-dependent pregnant women in Baltimore, MD, Providence, RI and Vienna, Austria.

Participants: Thirty-nine full-term infants.

Measurements: The Neonatal Intensive Care Unit (NICU) Network Neurobehavioral Scale (NNNS) was administered to a subgroup of infants on postpartum days 3, 5, 7, 10, 14-15 and 28-30.

Findings: While neurobehavior improved for both medication conditions over time, infants exposed in utero to buprenorphine exhibited fewer stress-abstinence signs (P < 0.001), were less excitable (P < 0.001) and less over-aroused (P < 0.01), exhibited less hypertonia (P < 0.007), had better self-regulation (P < 0.04) and required less handling (P < 0.001) to maintain a quiet alert state relative to in utero methadone-exposed infants. Infants who were older when they began morphine treatment for withdrawal had higher self-regulation scores (P < 0.01), and demonstrated the least amount of excitability (P < 0.02) and hypertonia (P < 0.02) on average. Quality of movement was correlated negatively with peak NAS score (P < 0.01), number of days treated with morphine for NAS (P < 0.01) and total amount of morphine received (P < 0.03). Excitability scores were related positively to total morphine dose (P < 0.03).

Conclusion: While neurobehavior improves during the first month of postnatal life for in utero agonist medication-exposed neonates, buprenorphine exposure results in superior neurobehavioral scores and less severe withdrawal than does methadone exposure.

Trial registration: ClinicalTrials.gov NCT00271219.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Average daily morphine dose (mg.) in the NNNS cohort measured on days congruent with NNNS assessment.
Figure 2
Figure 2
NNNS Summary Scores, trajectories over days of assessment.
See this image and copyright information in PMC

References

    1. Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM, et al. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcoh Dep. 2001;63:97–103. - PubMed
    1. Jones HE, Johnson RE, Jasinski DR, O’Grady KE, Chisholm CA, Choo RE, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Dep. 2005;79:1–10. - PubMed
    1. Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, et al. Treatment of opioid-dependent pregnant women with Buprenorphine. Addiction. 2000;95:239–244. - PubMed
    1. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S, Groupe d’Etudes Grossesse et Addictions (GEGA) Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend. 2006;82:250–57. - PubMed
    1. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, et al. Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction. 2006;101:275–81. - PubMed

Publication types

MeSH terms

Associated data